Gastric Bypass Surgery Support Group
Gastric bypass (GBP) is any of a group of similar operative procedures used to treat morbid obesity, a condition which arises from severe accumulation of excess weight in the form of fatty tissue, and the health problems ("co-morbidities") which result. If you are considering gastric bypass or have had it, join the community where we share our experiences and find support.
The EndoBarrier:A Promising No-Surgery Alternative
janairocky
The EndoBarrier: A Promising No-Surgery Alternative to Gastric Bypass -
Posted in Gastric Bypass ... by TeamDS on Oct 25, 2010
Gastric bypass is not without risk, but as thousands of formerly obese patients can attest, for most people it is effective. Now a new removable product called an EndoBarrier may provide the same results without the need for the trauma and recovery of invasive surgery.
The EndoBarrier Gastrointestinal Liner by GI Dynamics is a long, thin tube of balloon-like material that is designed to line the intestine, keeping food from touching the intestinal walls as this "may alter the activation of hormonal signals that originate in the intestine, thus mimicking the effects of a Roux-en-Y gastric bypass procedure without surgery." The device is inserted into a person's body endoscopically through the mouth, and the process is reversible.
After undergoing successful clinical trials with over 300 people, the product has recently received approval in Europe as a 12-month treatment option for obesity and type 2 diabetes. The EndoBarrier is still undergoing clinical trials in America, the home of the medical device company.
The data is impressive: patients in the clinical trials have lost "more than 20.0 percent of total body weight during 12 months of treatment." But now GI Dynamics has bigger plans: they are hard at work on another device called a EndoBarrier Flow Restrictor, that can be used in conjunction for even greater weight-loss. The Flow Restrictor allows for "an adjustable restriction at the outlet of the stomach and is designed to delay gastric emptying." When the two devices are used together, GI Dynamics expects double the weight-loss. That could equal an impressive 40 percent of total body weight in a year.
While the many variations of the Roux-en-Y gastric bypass have been performed successfully on hundreds of thousands of patients, the associated risks vary from problems such as anemia associated with nutritional deficiencies and leaks, to ulcers, infection, and even more serious complications like blood clots, and stomach or intestinal leaks.
Although there's no word yet on when the EndoBarrier Liner and Flow Restrictor will be approved in America, the prospects are good. So far, it appears like it's a best case scenario, where patients are being presented with new and safer options for common but important problems.
EndoBarrier Nutrition Tip: The EndoBarrier devices will most likely require people who use them to pay the same close attention to protein intake that occurs with gastric bypass patients. Supplementing with a high quality whey protein powder mixed into milk or water is frequently an easy and effective way to stay at your optimal protein intake.
Posted in Gastric Bypass ... by TeamDS on Oct 25, 2010
Gastric bypass is not without risk, but as thousands of formerly obese patients can attest, for most people it is effective. Now a new removable product called an EndoBarrier may provide the same results without the need for the trauma and recovery of invasive surgery.
The EndoBarrier Gastrointestinal Liner by GI Dynamics is a long, thin tube of balloon-like material that is designed to line the intestine, keeping food from touching the intestinal walls as this "may alter the activation of hormonal signals that originate in the intestine, thus mimicking the effects of a Roux-en-Y gastric bypass procedure without surgery." The device is inserted into a person's body endoscopically through the mouth, and the process is reversible.
After undergoing successful clinical trials with over 300 people, the product has recently received approval in Europe as a 12-month treatment option for obesity and type 2 diabetes. The EndoBarrier is still undergoing clinical trials in America, the home of the medical device company.
The data is impressive: patients in the clinical trials have lost "more than 20.0 percent of total body weight during 12 months of treatment." But now GI Dynamics has bigger plans: they are hard at work on another device called a EndoBarrier Flow Restrictor, that can be used in conjunction for even greater weight-loss. The Flow Restrictor allows for "an adjustable restriction at the outlet of the stomach and is designed to delay gastric emptying." When the two devices are used together, GI Dynamics expects double the weight-loss. That could equal an impressive 40 percent of total body weight in a year.
While the many variations of the Roux-en-Y gastric bypass have been performed successfully on hundreds of thousands of patients, the associated risks vary from problems such as anemia associated with nutritional deficiencies and leaks, to ulcers, infection, and even more serious complications like blood clots, and stomach or intestinal leaks.
Although there's no word yet on when the EndoBarrier Liner and Flow Restrictor will be approved in America, the prospects are good. So far, it appears like it's a best case scenario, where patients are being presented with new and safer options for common but important problems.
EndoBarrier Nutrition Tip: The EndoBarrier devices will most likely require people who use them to pay the same close attention to protein intake that occurs with gastric bypass patients. Supplementing with a high quality whey protein powder mixed into milk or water is frequently an easy and effective way to stay at your optimal protein intake.
deleted_user
Bump
farmgirl392
This actually sounds awful to me. I'd hate to have some foreign object stuck in me...Yuk. I'm really happy with my new post-GBS plumbing...
deleted_user
Lol, I agree. Especially where they put it. It's an interesting article tho
deleted_user
fergit it ....
Join the Conversation